Rainbow BioSciences, a division of Rainbow Coral Corp. (OTCBB: RBCC), is staying connected in the center of advanced bio-research in Houston.
To spearhead these efforts, RBCC attended a breakfast forum, hosted by BioHouston--one of the nation’s preeminent drivers of life sciences research and commercialization. Events such as these enable the Company to meet with the potential developers of the next breakthrough in bioscience research and get involved at the ground level.
RBCC works with early stage biotech entities that may hold the key to the next big advances in bioscience discoveries. Companies such as Advanced Cell Technology, Inc. are developing cellular therapies for the treatment of diseases and conditions that impact tens of millions of people worldwide. Connecting with forward-thinking and innovative leaders like Advanced Cell Technology could help RBCC develop and market the next big breakthrough in the industry.
Houston, TX is a recognized as an incubation hub for bioscience research and technology and is home to the world’s largest medical complex. RBCC will continue to attend Houston-based events to further solidify its place as a source for leading-edge bioscience initiatives.
For more information on Rainbow BioSciences, Rainbow Coral’s biotech division, please visit www.rainbowbiosciences.com/investors.
Rainbow BioSciences will develop new medical and research technology innovations to compete alongside companies such as Amgen Inc. (NASDAQ: AMGN), Biogen Idec, Inc. (NASDAQ: BIIB), Gilead Sciences, Inc. (NASDAQ: GILD) and Life Technologies Corporation (NASDAQ: LIFE).
Follow us on Twitter at www.twitter.com/RBCCinfo.
About Rainbow BioSciences
Rainbow BioSciences is a division of Rainbow Coral Corp. (OTCBB: RBCC.OB - News). The company continually seeks out new partnerships with biotechnology developers to deliver profitable new medical technologies and innovations. For more information on our growth-oriented business initiatives, please visit our website at [www.rainbowbiosciences.com]. For investment information and performance data on the company, please visit www.RainbowBioSciences.com/investors.
Notice Regarding Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of future success. This news release speaks as of the date first set forth above and the company assumes no responsibility to update the information included herein for events occurring after the date hereof.